Today, the National Safety Council released the following statement regarding President Trump's signing of an executive order ...

Precision Psychiatry Market is projected to reach US$ 4.2 Bn by 2035, driven by rapid integration of AI and ML in psychiatric ...

Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic ...

The 5 testing & diagnostics services stocks we track reported a very strong Q3. As a group, revenues beat analysts’ consensus ...

The company says it can turn profits without its customers facing the usual out-of-pocket costs or high premiums. Economists ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

During the year, the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.

In recent days, Simply Good Foods drew attention as analysts reiterated positive views ahead of its now-past January 8, 2026 first-quarter earnings release, while the company secured a US$150,000,000 ...

Although this is one route for a diagnostic device, securing FDA approval allows Cleveland Diagnostics to send IsoPSA kits out to every lab in the U.S. that has an immunoanalyzer — a diagnostic ...

Quest Diagnostics Incorporated , a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and ...

A new blood test from Quest Diagnostics has Alzheimer's experts concerned. The Quest AD-Detect test, which consumers can now purchase from home without visiting a doctor first, measures amyloid-beta ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...